Cargando…

Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124

Detalles Bibliográficos
Autores principales: Novo, Salvatore, Fazio, Giovanni, Raccuglia, Elena, Mignano, Antonino, Novo, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060125/
https://www.ncbi.nlm.nih.gov/pubmed/27721326
http://dx.doi.org/10.3390/ph4101293
_version_ 1782321326216708096
author Novo, Salvatore
Fazio, Giovanni
Raccuglia, Elena
Mignano, Antonino
Novo, Giuseppina
author_facet Novo, Salvatore
Fazio, Giovanni
Raccuglia, Elena
Mignano, Antonino
Novo, Giuseppina
author_sort Novo, Salvatore
collection PubMed
description
format Online
Article
Text
id pubmed-4060125
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40601252014-06-17 Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124 Novo, Salvatore Fazio, Giovanni Raccuglia, Elena Mignano, Antonino Novo, Giuseppina Pharmaceuticals (Basel) Correction MDPI 2011-09-30 /pmc/articles/PMC4060125/ /pubmed/27721326 http://dx.doi.org/10.3390/ph4101293 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Correction
Novo, Salvatore
Fazio, Giovanni
Raccuglia, Elena
Mignano, Antonino
Novo, Giuseppina
Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title_full Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title_fullStr Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title_full_unstemmed Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title_short Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124
title_sort novo, s. et al. aliskiren: just a new drug for few selected patients or an innovative molecule predestinated to replace arbs and ace-inhibitors? pharmaceuticals 2009, 2, 118-124
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060125/
https://www.ncbi.nlm.nih.gov/pubmed/27721326
http://dx.doi.org/10.3390/ph4101293
work_keys_str_mv AT novosalvatore novosetalaliskirenjustanewdrugforfewselectedpatientsoraninnovativemoleculepredestinatedtoreplacearbsandaceinhibitorspharmaceuticals20092118124
AT faziogiovanni novosetalaliskirenjustanewdrugforfewselectedpatientsoraninnovativemoleculepredestinatedtoreplacearbsandaceinhibitorspharmaceuticals20092118124
AT raccugliaelena novosetalaliskirenjustanewdrugforfewselectedpatientsoraninnovativemoleculepredestinatedtoreplacearbsandaceinhibitorspharmaceuticals20092118124
AT mignanoantonino novosetalaliskirenjustanewdrugforfewselectedpatientsoraninnovativemoleculepredestinatedtoreplacearbsandaceinhibitorspharmaceuticals20092118124
AT novogiuseppina novosetalaliskirenjustanewdrugforfewselectedpatientsoraninnovativemoleculepredestinatedtoreplacearbsandaceinhibitorspharmaceuticals20092118124